The NHS England will reportedly introduce a new independent review group to assess puberty blocker prescriptions. The news comes after a March ruling, which gave parents the ability to give consent regarding gender-affirming treatments for their child.
In a statement from the NHS, the organization gave details on the group and what families can expect from the interim changes. “As an interim measure, and in direct response to the Court’s suggestion that additional safeguards may be warranted, a new independent multidisciplinary professional review group will be established to confirm decision-making has followed a robust process,” the NHS England stated. “This group will be comprised of health and care professionals with expertise in child